Unicycive Therapeutics, Inc. (UNCY) SEC Filings — 2024

Filings

• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Unicycive Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Unicycive Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 13, 2024
• Unicycive Therapeutics Files 8-K Report — 8-K · Nov 12, 2024
• Unicycive Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 11, 2024
• Unicycive Therapeutics Closes $10M Public Offering — 8-K · Sep 25, 2024
• Unicycive Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Unicycive Therapeutics, Inc. SC 13G Filing — SC 13G · Jul 18, 2024
• Unicycive Therapeutics Faces Delisting Concerns — 8-K · Jul 15, 2024
• Unicycive Therapeutics Enters Material Definitive Agreement — 8-K · Jul 2, 2024
• Unicycive Therapeutics Changes Fiscal Year End — 8-K · Jun 26, 2024
• Unicycive Therapeutics Files 8-K for Office Location — 8-K · Jun 25, 2024
• Unicycive Therapeutics Holds Annual Stockholder Meeting — 8-K · Jun 20, 2024
• Unicycive Therapeutics, Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 13, 2024
• Unicycive Therapeutics Files Definitive Additional Materials — DEFA14A · May 8, 2024
• Unicycive Therapeutics Announces Annual Meeting on June 20, 2024, to Elect Directors and Vote on Share Increase — DEF 14A · Apr 26, 2024
• Unicycive Therapeutics Files 8-K — 8-K · Mar 29, 2024
• Unicycive Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Unicycive Therapeutics Files 8-K with Material Agreements — 8-K · Mar 14, 2024
• Unicycive Therapeutics Files 8-K for 'Other Events' — 8-K · Feb 21, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Unicycive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Nantahala Capital Takes 9.9% Stake in Unicycive Therapeutics — SC 13G · Feb 5, 2024
• Logos Global Management Takes 5.1% Stake in Unicycive Therapeutics — SC 13G · Jan 22, 2024